Current advances and challenges in mpox vaccine development: a global landscape
Given the surge in mpox outbreaks in 2022 and the advancements in domestic and international vaccine research, the effectiveness of smallpox vaccines in providing cross-protection against mpox remains crucial. Having learned from the COVID-19 pandemic, it is significant to continue evaluating existi...
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SAGE Publishing
2025-01-01
|
| Series: | Therapeutic Advances in Vaccines and Immunotherapy |
| Online Access: | https://doi.org/10.1177/25151355251314339 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832584162358329344 |
|---|---|
| author | Maryam Shafaati Shayan Forghani Amirhossein Shahsavand Davoudi Reza Samiee Keyhan Mohammadi Samaneh Akbarpour Arash Seifi Mohammadreza Salehi Maryam Zare |
| author_facet | Maryam Shafaati Shayan Forghani Amirhossein Shahsavand Davoudi Reza Samiee Keyhan Mohammadi Samaneh Akbarpour Arash Seifi Mohammadreza Salehi Maryam Zare |
| author_sort | Maryam Shafaati |
| collection | DOAJ |
| description | Given the surge in mpox outbreaks in 2022 and the advancements in domestic and international vaccine research, the effectiveness of smallpox vaccines in providing cross-protection against mpox remains crucial. Having learned from the COVID-19 pandemic, it is significant to continue evaluating existing vaccines to ensure their safety and efficacy. Developing new vaccines for widespread use against mpox and its emerging strains also serves as a preventive strategy in the ongoing battle against this dynamic infection. Here’s an opportunity to control human-to-human transmission, give short deadlines, and avoid vaccine disparity. Public health systems must take decisive action to prevent the global spread of mpox, particularly among vulnerable groups. This action should include strengthening global surveillance, improving vaccine access, and ensuring equitable distribution, particularly in resource-poor settings, to prevent future outbreaks. This review aims to assess recent advancements and barriers in mpox vaccine development, emphasizing cross-protection and equitable vaccine distribution in resource-poor settings. |
| format | Article |
| id | doaj-art-28d22a126c7d4c8a9d15968c42914d4b |
| institution | Kabale University |
| issn | 2515-1363 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | SAGE Publishing |
| record_format | Article |
| series | Therapeutic Advances in Vaccines and Immunotherapy |
| spelling | doaj-art-28d22a126c7d4c8a9d15968c42914d4b2025-01-27T15:04:01ZengSAGE PublishingTherapeutic Advances in Vaccines and Immunotherapy2515-13632025-01-011310.1177/25151355251314339Current advances and challenges in mpox vaccine development: a global landscapeMaryam ShafaatiShayan ForghaniAmirhossein Shahsavand DavoudiReza SamieeKeyhan MohammadiSamaneh AkbarpourArash SeifiMohammadreza SalehiMaryam ZareGiven the surge in mpox outbreaks in 2022 and the advancements in domestic and international vaccine research, the effectiveness of smallpox vaccines in providing cross-protection against mpox remains crucial. Having learned from the COVID-19 pandemic, it is significant to continue evaluating existing vaccines to ensure their safety and efficacy. Developing new vaccines for widespread use against mpox and its emerging strains also serves as a preventive strategy in the ongoing battle against this dynamic infection. Here’s an opportunity to control human-to-human transmission, give short deadlines, and avoid vaccine disparity. Public health systems must take decisive action to prevent the global spread of mpox, particularly among vulnerable groups. This action should include strengthening global surveillance, improving vaccine access, and ensuring equitable distribution, particularly in resource-poor settings, to prevent future outbreaks. This review aims to assess recent advancements and barriers in mpox vaccine development, emphasizing cross-protection and equitable vaccine distribution in resource-poor settings.https://doi.org/10.1177/25151355251314339 |
| spellingShingle | Maryam Shafaati Shayan Forghani Amirhossein Shahsavand Davoudi Reza Samiee Keyhan Mohammadi Samaneh Akbarpour Arash Seifi Mohammadreza Salehi Maryam Zare Current advances and challenges in mpox vaccine development: a global landscape Therapeutic Advances in Vaccines and Immunotherapy |
| title | Current advances and challenges in mpox vaccine development: a global landscape |
| title_full | Current advances and challenges in mpox vaccine development: a global landscape |
| title_fullStr | Current advances and challenges in mpox vaccine development: a global landscape |
| title_full_unstemmed | Current advances and challenges in mpox vaccine development: a global landscape |
| title_short | Current advances and challenges in mpox vaccine development: a global landscape |
| title_sort | current advances and challenges in mpox vaccine development a global landscape |
| url | https://doi.org/10.1177/25151355251314339 |
| work_keys_str_mv | AT maryamshafaati currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT shayanforghani currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT amirhosseinshahsavanddavoudi currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT rezasamiee currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT keyhanmohammadi currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT samanehakbarpour currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT arashseifi currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT mohammadrezasalehi currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape AT maryamzare currentadvancesandchallengesinmpoxvaccinedevelopmentagloballandscape |